Renescience A/S: Financial statements 2024
CVR: 31846803
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Renescience A/S (CVR 31846803) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 10,836,000 and a net result of DKK -23,904,000 compared with DKK -194,649,000 the year before. That is an increase of 4% compared with the year before. The profit margin was -220.6%. Equity in the 2024 report amounted to DKK 7,407,000. The solvency ratio was 50.8%. The company had 1,000 employees in the financial year.
- Revenue
- DKK 10,836,000
- Gross Profit
- DKK -15,360,000
- Profit/Loss
- DKK -23,904,000
- Equity
- DKK 7,407,000
- Total Assets
- DKK 14,580,000
- Employees
- 1,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 10.8 mio. | -15.4 mio. | -23.9 mio. | 7.4 mio. | 1000 |
| 2023 | 10.4 mio. | -13.5 mio. | -194.6 mio. | -11.7 mio. | 0 |
| 2022 | 10.8 mio. | -10.9 mio. | -13.3 mio. | 183 mio. | 0 |
| 2021 | 8 mio. | -11.4 mio. | -8.3 mio. | 22.8 mio. | - |
| 2020 | 1.7 mio. | -16.6 mio. | -13.5 mio. | 31.1 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of December 20, 2024, Lars Holm Lerke-Møller has joined the board of directors of Renescience A/S.
As of December 20, 2024, Hanne Risbjerg Sørensen has left the board of directors of Renescience A/S.
As of December 20, 2024, Lars Holm Lerke-Møller is registered as director of Renescience A/S.
As of December 20, 2024, Hanne Risbjerg Sørensen has stepped down as director of Renescience A/S.
Renescience A/S has published its annual report for 2023. Revenue came to DKK 10,419,000, and the net result was DKK -194,649,000.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RENESCIENCE A/S and DE S&D NR. 1 2008 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. According to the 2025 annual report, the company had an average of 1,000 employees. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity in the 2025 report amounted to DKK 73,470,000.